Alkermes' Corporate Presentation to be Webcast at the 33rd Annual J.P. Morgan Healthcare Conference

Loading...
Loading...
DUBLIN--(BUSINESS WIRE)--

Alkermes plc ALKS announced today that its corporate presentation will be webcast live at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, 2015, at 7:30 a.m. PST (10:30 a.m. EST/3:30 p.m. GMT) from the Westin St. Francis Hotel in San Francisco. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and manufacturing facilities in Gainesville, Georgia and Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes plc
Eva Stroynowski, +1 781 609 6823
Corporate Communications

Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...